Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Ekeibed Y"" wg kryterium: Autor


Wyświetlanie 1-5 z 5
Tytuł:
Spontaneous Remission in a Patient with Chronic Myeloid Leukemia: A Case Report.
Autorzy:
Alshurafa A; Department of Hematology, Hamad Medical Corporation, Doha, Qatar.
Ekeibed Y; Department of Hematology, Hamad Medical Corporation, Doha, Qatar.
Akiki S; Department of Diagnostic Laboratory, Hamad Medical Corporation, Doha, Qatar.
Alzeyara M; Department of Diagnostic Laboratory, Hamad Medical Corporation, Doha, Qatar.
Nawaz Z; Department of Diagnostic Laboratory, Hamad Medical Corporation, Doha, Qatar.
Yassin MA; Department of Hematology, Hamad Medical Corporation, Doha, Qatar.
Pokaż więcej
Źródło:
Case reports in oncology [Case Rep Oncol] 2023 Oct 06; Vol. 16 (1), pp. 1073-1079. Date of Electronic Publication: 2023 Oct 06 (Print Publication: 2023).
Typ publikacji:
Case Reports
Raport
Tytuł:
Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia.
Autorzy:
Basha A; National Center for Cancer Care and Research (NCCCR), Pharmacy Department, HMC, Doha, Qatar.
Ibrahim MIM; Clinical Pharmacy and Practice Department, College of Pharmacy, QU Health, Qatar University, Doha, Qatar.
Hamad A; National Center for Cancer Care and Research (NCCCR), Pharmacy Department, HMC, Doha, Qatar.
Chandra P; National Center for Cancer Care and Research (NCCCR), Pharmacy Department, HMC, Doha, Qatar.
Omar NE; National Center for Cancer Care and Research (NCCCR), Pharmacy Department, HMC, Doha, Qatar.
Abdullah MAJ; National Center for Cancer Care and Research, Hematology Department, HMC, Doha, Qatar.
Aldapt MB; National Center for Cancer Care and Research, Hematology Department, HMC, Doha, Qatar.
Hussein RM; National Center for Cancer Care and Research (NCCCR), Pharmacy Department, HMC, Doha, Qatar.
Mahfouz A; Heart Hospital (HH), Pharmacy Department, HMC, Doha, Qatar.
Adel AA; National Center for Cancer Care and Research (NCCCR), Pharmacy Department, HMC, Doha, Qatar.
Shwaylia HM; National Center for Cancer Care and Research, Hematology Department, HMC, Doha, Qatar.
Ekeibed Y; National Center for Cancer Care and Research, Hematology Department, HMC, Doha, Qatar.
AbuMousa R; National Center for Cancer Care and Research (NCCCR), Pharmacy Department, HMC, Doha, Qatar.
Yassin MA; National Center for Cancer Care and Research, Hematology Department, HMC, Doha, Qatar.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Aug 10; Vol. 16 (8), pp. e0255104. Date of Electronic Publication: 2021 Aug 10 (Print Publication: 2021).
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Cost-Benefit Analysis*
Anemia, Iron-Deficiency/*drug therapy
Anemia, Iron-Deficiency/*economics
Ferric Compounds/*administration & dosage
Ferric Compounds/*therapeutic use
Ferric Oxide, Saccharated/*administration & dosage
Ferric Oxide, Saccharated/*therapeutic use
Maltose/*analogs & derivatives
Administration, Intravenous ; Adult ; Aged ; Female ; Ferric Compounds/economics ; Ferric Oxide, Saccharated/economics ; Health Expenditures ; Humans ; Male ; Maltose/administration & dosage ; Maltose/economics ; Maltose/therapeutic use ; Middle Aged ; Treatment Outcome ; Young Adult
Czasopismo naukowe
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies